Import Alert

GettyImages/Traitov

OTC makers hit with US FDA warning letters

By Staff Reporter

Two Chinese and one Korean over-the-counter (OTC) drugmakers have received US FDA warnings for violating good manufacturing practice (GMP) regulations for finished pharmaceuticals.

FDA adds 4 API manufacturers to 'Red List'

FDA adds 4 API manufacturers to 'Red List'

By Melissa Fassbender

Two Chinese and two Indian companies have been banned from importing APIs to the US – one manufacturer says it’s making GMP compliance a “priority.”

Sun down on latest Indian US FDA import alert

Sun down on latest Indian US FDA import alert

By Dan Stanton

Sun Pharma’s antibiotic facility import alert is the latest blow to the Indian drug industry but is unlikely to impact revenues or cause US shortages, the firm says.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers